199 related articles for article (PubMed ID: 25871838)
1. Differential Gene Expression in Diabetic Nephropathy in Individuals With Type 1 Diabetes.
Caramori ML; Kim Y; Goldfine AB; Moore JH; Rich SS; Mychaleckyj JC; Kirkpatrick D; Nickerson H; Krolewski AS; Mauer M
J Clin Endocrinol Metab; 2015 Jun; 100(6):E876-82. PubMed ID: 25871838
[TBL] [Abstract][Full Text] [Related]
2. Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 Diabetes.
Caramori ML; Kim Y; Natarajan R; Moore JH; Rich SS; Mychaleckyj JC; Kuriyama R; Kirkpatrick D; Mauer M
J Clin Endocrinol Metab; 2015 Jun; 100(6):E883-9. PubMed ID: 25901990
[TBL] [Abstract][Full Text] [Related]
3. IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy.
Gu T; Horová E; Möllsten A; Seman NA; Falhammar H; Prázný M; Brismar K; Gu HF
J Diabetes Complications; 2012; 26(5):393-8. PubMed ID: 22770937
[TBL] [Abstract][Full Text] [Related]
4. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
Zhang D; Ma J; Brismar K; Efendic S; Gu HF
J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
Yu ZY; Chen LS; Zhang LC; Zhou TB
Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
[TBL] [Abstract][Full Text] [Related]
6. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
7. New susceptibility loci associated with kidney disease in type 1 diabetes.
Sandholm N; Salem RM; McKnight AJ; Brennan EP; Forsblom C; Isakova T; McKay GJ; Williams WW; Sadlier DM; Mäkinen VP; Swan EJ; Palmer C; Boright AP; Ahlqvist E; Deshmukh HA; Keller BJ; Huang H; Ahola AJ; Fagerholm E; Gordin D; Harjutsalo V; He B; Heikkilä O; Hietala K; Kytö J; Lahermo P; Lehto M; Lithovius R; Osterholm AM; Parkkonen M; Pitkäniemi J; Rosengård-Bärlund M; Saraheimo M; Sarti C; Söderlund J; Soro-Paavonen A; Syreeni A; Thorn LM; Tikkanen H; Tolonen N; Tryggvason K; Tuomilehto J; Wadén J; Gill GV; Prior S; Guiducci C; Mirel DB; Taylor A; Hosseini SM; ; Parving HH; Rossing P; Tarnow L; Ladenvall C; Alhenc-Gelas F; Lefebvre P; Rigalleau V; Roussel R; Tregouet DA; Maestroni A; Maestroni S; Falhammar H; Gu T; Möllsten A; Cimponeriu D; Ioana M; Mota M; Mota E; Serafinceanu C; Stavarachi M; Hanson RL; Nelson RG; Kretzler M; Colhoun HM; Panduru NM; Gu HF; Brismar K; Zerbini G; Hadjadj S; Marre M; Groop L; Lajer M; Bull SB; Waggott D; Paterson AD; Savage DA; Bain SC; Martin F; Hirschhorn JN; Godson C; Florez JC; Groop PH; Maxwell AP
PLoS Genet; 2012 Sep; 8(9):e1002921. PubMed ID: 23028342
[TBL] [Abstract][Full Text] [Related]
8. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.
Möllsten A; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
Ann Med; 2006; 38(7):522-8. PubMed ID: 17101543
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes.
Panduru NM; Moţa E; Moţa M; Cimponeriu D; Serafinceanu C; Cheţa DM
Rom J Intern Med; 2010; 48(1):81-8. PubMed ID: 21180245
[TBL] [Abstract][Full Text] [Related]
10. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations.
Ma J; Nordman S; Möllsten A; Falhammar H; Brismar K; Dahlquist G; Efendic S; Gu HF
Eur J Endocrinol; 2007 Nov; 157(5):641-5. PubMed ID: 17984244
[TBL] [Abstract][Full Text] [Related]
11. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group.
Schmidt S; Giessel R; Bergis KH; Strojek K; Grzeszczak W; Ganten D; Ritz E
Nephrol Dial Transplant; 1996 Sep; 11(9):1755-61. PubMed ID: 8918618
[TBL] [Abstract][Full Text] [Related]
12. Glutathione reverses the growth abnormalities of skin fibroblasts from insulin-dependent diabetic patients with nephropathy.
Morocutti A; Sethi M; Hayward A; Lee A; Viberti G
J Am Soc Nephrol; 1998 Jun; 9(6):1060-6. PubMed ID: 9621289
[TBL] [Abstract][Full Text] [Related]
13. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.
Alkhalaf A; Bakker SJ; Bilo HJ; Gans RO; Navis GJ; Postmus D; Forsblom C; Groop PH; Vionnet N; Hadjadj S; Marre M; Parving HH; Rossing P; Tarnow L
Diabetologia; 2010 Dec; 53(12):2562-8. PubMed ID: 20711718
[TBL] [Abstract][Full Text] [Related]
14. Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population.
Amor AJ; Canivell S; Oriola J; Ricart MJ; de Hollanda AM; Bosch-Comas A; Esmatjes E
Nefrologia; 2014; 34(2):212-5. PubMed ID: 24658196
[TBL] [Abstract][Full Text] [Related]
15. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
[TBL] [Abstract][Full Text] [Related]
16. Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes.
Monteiro MB; Thieme K; Santos-Bezerra DP; Queiroz MS; Woronik V; Passarelli M; Machado UF; Giannella-Neto D; Oliveira-Souza M; Corrêa-Giannella ML
Metabolism; 2016 Jun; 65(6):816-24. PubMed ID: 27173460
[TBL] [Abstract][Full Text] [Related]
17. Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy.
Ma J; Möllsten A; Prázny M; Falhammar H; Brismar K; Dahlquist G; Efendic S; Gu HF
Diabet Med; 2006 Oct; 23(10):1093-9. PubMed ID: 16978373
[TBL] [Abstract][Full Text] [Related]
18. Caldesmon over-expression in type 1 diabetic nephropathy.
Millioni R; Iori E; Lenzini L; Puricelli L; Caroccia B; Arrigoni G; Rossi GP; Tessari P
J Diabetes Complications; 2011; 25(2):114-21. PubMed ID: 20801058
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
[TBL] [Abstract][Full Text] [Related]
20. A family-based strategy to identify genes for diabetic nephropathy.
Covic AM; Iyengar SK; Olson JM; Sehgal AR; Constantiner M; Jedrey C; Kara M; Sabbagh E; Sedor JR; Schelling JR
Am J Kidney Dis; 2001 Mar; 37(3):638-47. PubMed ID: 11228193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
